Citadel Advisors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-107,953
| Closed | -$65K | – | 7135 |
|
|
2022
Q2 | $65K | Buy |
+107,953
| New | +$65K | ﹤0.01% | 5434 |
|
|
2022
Q1 | – | Sell |
-37,452
| Closed | -$98K | – | 7539 |
|
|
2021
Q4 | $98K | Buy |
37,452
+23,545
| +169% | +$61.6K | ﹤0.01% | 5921 |
|
|
2021
Q3 | $43K | Sell |
13,907
-26,477
| -66% | -$81.9K | ﹤0.01% | 6161 |
|
|
2021
Q2 | $150K | Buy |
40,384
+26,660
| +194% | +$99K | ﹤0.01% | 5756 |
|
|
2021
Q1 | $47K | Sell |
13,724
-8,969
| -40% | -$30.7K | ﹤0.01% | 6113 |
|
|
2020
Q4 | $76K | Buy |
22,693
+7,166
| +46% | +$24K | ﹤0.01% | 4758 |
|
|
2020
Q3 | $54K | Sell |
15,527
-137
| -0.9% | -$476 | ﹤0.01% | 4383 |
|
|
2020
Q2 | $72K | Buy |
+15,664
| New | +$72K | ﹤0.01% | 4299 |
|